サマリー

サイトメガロウイルス（CMV）治療薬の世界市場2022-2026年
Technavioはサイトメガロウイルス（CMV）治療薬市場を監視しており、2022-2026年の間に332.21百万ドル、予測期間中にCAGR 5.44%で加速して成長すると予測しています。当レポートでは、サイトメガロウイルス（CMV）治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、CMVのリスク要因の増加、疾患の再発性、先天性CMVの高い有病率によって牽引されています。
サイトメガロウイルス（CMV）治療薬市場の分析には、投与経路セグメントと地理的状況も含まれます。
Technavioのサイトメガロウイルス（CMV）治療薬市場は、以下のようにセグメント化されています。
投与経路別
- 経口
- 非経口投与
- その他
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるサイトメガロウイルス（CMV）治療薬市場の成長を促進する主な理由の一つとして、薬剤の再製剤化を挙げています。また、ワクチンと新生児スクリーニングの出現は、市場の大規模な需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。サイトメガロウイルス（CMV）治療薬市場に関する当レポートは、以下の分野を対象としています。
- サイトメガロウイルス（CMV）治療薬の市場サイジング
- サイトメガロウイルス（CMV）治療薬の市場予測
- サイトメガロウイルス（CMV）治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、アステラス製薬株式会社、AstraZeneca Plc、Bausch Health Companies Inc、Chimerix Inc、Clinigen Group Plc、Exela Pharma Sciences LLC、F. Hoffmann La Roche Ltd., Fortress Biotech Inc, Fresenius SE、及びCo.KGaA、Genentech Inc.、Gilead Sciences Inc.、Merck and Co.Inc.、武田薬品工業株式会社Ltd.、Teva Pharmaceutical Industries Ltd.、Thermo Fisher Scientific Inc.、UbiVac、およびVBI Vaccines Inc.の7社が含まれています。また、サイトメガロウイルス（CMV）治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/cytomegalovirus-cmv-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Oral - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.4 Parenteral - Market size and forecast 2021-2026
o Exhibit 32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Route of Administration
o Exhibit 40: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Denmark - Market size and forecast 2021-2026
o Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 89: AstraZeneca Plc - Overview
o Exhibit 90: AstraZeneca Plc - Product / Service
o Exhibit 91: AstraZeneca Plc - Key news
o Exhibit 92: AstraZeneca Plc - Key offerings
o 10.4 Bausch Health Companies Inc.
o Exhibit 93: Bausch Health Companies Inc. - Overview
o Exhibit 94: Bausch Health Companies Inc. - Business segments
o Exhibit 95: Bausch Health Companies Inc. - Key news
o Exhibit 96: Bausch Health Companies Inc. - Key offerings
o Exhibit 97: Bausch Health Companies Inc. - Segment focus
o 10.5 Chimerix Inc.
o Exhibit 98: Chimerix Inc. - Overview
o Exhibit 99: Chimerix Inc. - Product / Service
o Exhibit 100: Chimerix Inc. - Key offerings
o 10.6 Exela Pharma Sciences LLC
o Exhibit 101: Exela Pharma Sciences LLC - Overview
o Exhibit 102: Exela Pharma Sciences LLC - Product / Service
o Exhibit 103: Exela Pharma Sciences LLC - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 104: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 105: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 106: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 107: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 108: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 Fortress Biotech Inc.
o Exhibit 109: Fortress Biotech Inc. - Overview
o Exhibit 110: Fortress Biotech Inc. - Business segments
o Exhibit 111: Fortress Biotech Inc. - Key offerings
o Exhibit 112: Fortress Biotech Inc. - Segment focus
o 10.9 Gilead Sciences Inc.
o Exhibit 113: Gilead Sciences Inc. - Overview
o Exhibit 114: Gilead Sciences Inc. - Product / Service
o Exhibit 115: Gilead Sciences Inc. - Key news
o Exhibit 116: Gilead Sciences Inc. - Key offerings
o 10.10 Merck and Co. Inc.
o Exhibit 117: Merck and Co. Inc. - Overview
o Exhibit 118: Merck and Co. Inc. - Business segments
o Exhibit 119: Merck and Co. Inc. - Key news
o Exhibit 120: Merck and Co. Inc. - Key offerings
o Exhibit 121: Merck and Co. Inc. - Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Route of Administration ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AstraZeneca Plc - Overview
Exhibits90: AstraZeneca Plc - Product / Service
Exhibits91: AstraZeneca Plc - Key news
Exhibits92: AstraZeneca Plc - Key offerings
Exhibits93: Bausch Health Companies Inc. - Overview
Exhibits94: Bausch Health Companies Inc. - Business segments
Exhibits95: Bausch Health Companies Inc. - Key news
Exhibits96: Bausch Health Companies Inc. - Key offerings
Exhibits97: Bausch Health Companies Inc. - Segment focus
Exhibits98: Chimerix Inc. - Overview
Exhibits99: Chimerix Inc. - Product / Service
Exhibits100: Chimerix Inc. - Key offerings
Exhibits101: Exela Pharma Sciences LLC - Overview
Exhibits102: Exela Pharma Sciences LLC - Product / Service
Exhibits103: Exela Pharma Sciences LLC - Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. - Overview
Exhibits105: F. Hoffmann La Roche Ltd. - Business segments
Exhibits106: F. Hoffmann La Roche Ltd. - Key news
Exhibits107: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits108: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits109: Fortress Biotech Inc. - Overview
Exhibits110: Fortress Biotech Inc. - Business segments
Exhibits111: Fortress Biotech Inc. - Key offerings
Exhibits112: Fortress Biotech Inc. - Segment focus
Exhibits113: Gilead Sciences Inc. - Overview
Exhibits114: Gilead Sciences Inc. - Product / Service
Exhibits115: Gilead Sciences Inc. - Key news
Exhibits116: Gilead Sciences Inc. - Key offerings
Exhibits117: Merck and Co. Inc. - Overview
Exhibits118: Merck and Co. Inc. - Business segments
Exhibits119: Merck and Co. Inc. - Key news
Exhibits120: Merck and Co. Inc. - Key offerings
Exhibits121: Merck and Co. Inc. - Segment focus
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits123: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits124: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits125: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits130: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations